95% stored in skeletal muscle
The body stores 95% of its total creatine in skeletal muscle, even though creatine is only synthesized in the liver and brain.
Snapshot · The Diary Of A CEO with Steven Bartlett
Creatine Expert: Creatine Is The Secret To Weight Loss
Explore episode
Jun 15, 2026
Where this was said
Dr. Candow's Research Journey
At 6:38 · chapter starts 5:03
Dr. Candow traces his path from glutamine research to creatine, explains creatine's physiological role in ATP energy maintenance, and describes how the body synthesises and stores it.
Why Vegans Are Creatine's Biggest Winners
Creatine is found exclusively in animal flesh. Vegans and vegetarians synthesise about 1–3g daily through amino acids but get none from food, meaning they start with the lowest stores and respond the most dramatically to supplementation.
Vegans respond best to creatine
Vegans and vegetarians respond better to creatine supplementation than meat-eaters because they start with lower baseline creatine stores from their diet.
1 gram creatine from food requires large meat intake
Getting just 3 grams of dietary creatine requires consuming a large amount of red meat or seafood, making supplementation a practical alternative.
The 5 Creatine Myths Debunked
Creatine doesn't damage kidneys, cause hair loss, make you bloated long-term, or cramp your muscles. It's not only for men. Every one of these widely-held myths is contradicted by randomised controlled trial evidence.
Similar snapshots
540M years ago: first animal vision
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
50% of cortex involved in vision
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Human 6-year-olds learn tens of thousands of object categories
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
~3% of FDA drugs have unclear mechanisms
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
30–50% of phase 1 drugs fail to reach phase 2
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
BPC-157 published work: >80% from one group
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
~100 approved peptide drugs; ~150 in trials
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
BPC-157 founder withheld screening method
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
Brain barely distinguishes imagined vs real
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
